CARDINAL HEALTH 17%-20% INTERNAL GROWTH PREDICTED FOR FOURTH QUARTER AND FY 1996; DRUG PRICE INCREASES ENHANCE MCKESSON FOURTH QUARTER REVENUES
Executive Summary
Cardinal Health's predicted 17%-20% internal growth rate for the upcoming quarter should continue through FY 1996, with the fast growing generics segment accounting for a healthy percentage of pharmaceutical profits, Cardinal Chief Financial Officer David Bearman said during an April 24 teleconference.